Live Breaking News & Updates on Aesica Pharmaceuticals Ltd

Share this article
Share this article
ResearchAndMarkets.com s offering.
The global market for active pharmaceutical ingredients (APIs) should grow from $135.4 billion in 2020 to $173.3 billion by 2025, at a compound annual growth rate (CAGR) of 5.1% for the period of 2020-2025.
This report is an overview of the pharmaceutical industry landscape and active pharmaceutical ingredients (API), along with the current trends and dynamics shaping the API market landscape. API sourcing trends and regulatory guidelines that impact the procurement of APIs are studied here. The increasing importance of outsourced API manufacturing activities and the impact on the pharmaceutical industry are covered in the report. ....

United States , Bcmos Cdmos , Aurobindo Pharma , Biosimilar Apis , Laura Wood , Teva Pharmaceutical Industries Inc , Glaxosmithkline Plc , Actavis Plc , Boehringer Ingelheim , Zhejiang Chemicals Import Export Corp , Sun Pharmaceutical Industries Ltd , Johnson Matthey Pharmaceutical Materials Inc , Aesica Pharmaceuticals Ltd , Threat Of Substitute Products Or Services , Avid Bioservices Inc , Dr Reddy Laboratory , Piramal Pharma Solutions , Fareva Group , Cost Of Drug Development , Shandong Xinhua Pharmaceutical Co , Custom Research , Dishman Group , Cambrex Corp , Office Hours Call , Divis Laboratories Ltd , Zhuhai United Laboratories Co ,